Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 361 AL 375

Role of Flavonoids in Management of Various Biological Targets in Alzheimer's Disease: Evidence from Preclinical to Clinical Studies

Alharbi KS, Javed Shaikh MA, Imam SS, Alshehri S, Ghoneim MM, Almalki WH, Singh SK, Kumar D, Kumar AP, Dua K, Chellappan DK, Paudel KR, Gupta G.

Curr Med Chem. 2023;30(18):2061-2074. doi: 10.2174/0929867330666221122115212.

Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial

Petrella JR, Michael AM, Qian M, Nwosu A, Sneed J, Goldberg TE, Devanand DP, Doraiswamy PM.

J Alzheimers Dis. 2023;91(1):483-494. doi: 10.3233/JAD-220946.

Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer's Disease

Lansdall CJ, McDougall F, Butler LM, Delmar P, Pross N, Qin S, McLeod L, Zhou X, Kerchner GA, Doody RS.

J Prev Alzheimers Dis. 2023;10(1):9-18. doi: 10.14283/jpad.2022.102.

Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis

Bonvicini M, Travaglini S, Lelli D, Antonelli Incalzi R, Pedone C.

Nutrients. 2023 Jan 12;15(2):386. doi: 10.3390/nu15020386.

State-of-the-art therapy for Down syndrome

Lorenzon N, Musoles-Lleó J, Turrisi F, Gomis-González M, De La Torre R, Dierssen M.

Dev Med Child Neurol. 2023 Jul;65(7):870-884. doi: 10.1111/dmcn.15517. Epub 2023 Jan 24.

Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer's dementia: a randomized controlled trial

Wunderlich G, Blahova Z, Garcia M, Jessen F.

Alzheimers Res Ther. 2023 Jan 28;15(1):24. doi: 10.1186/s13195-023-01163-3.

Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study

Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z, Zheng H, Fisseha N, Kalluri HV, Rendenbach-Mueller B, Budur K, Gold M.

Brain. 2023 Jun 1;146(6):2275-2284. doi: 10.1093/brain/awad024.

Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?

Mills ZB, Faull RLM, Kwakowsky A.

Int J Mol Sci. 2023 Feb 6;24(4):3205. doi: 10.3390/ijms24043205.

A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up Study

Pakdaman H, Amini Harandi A, Gharagozli K, Siavoshi F, Shirzadeh Barough S, Sharifipour E, Esfandani A, Ilkhani S, Tabatabaei FS, Sobhanian SA.

Curr Aging Sci. 2023;16(3):234-239. doi: 10.2174/1874609816666230224111759.

Complementary and Alternative Medicine Approaches in Alzheimer Disease and Other Neurocognitive Disorders

Beversdorf DQ, Crosby HW, Shenker JI.

Mo Med. 2023 Jan-Feb;120(1):70-78.

Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation

Zhang M, Tang Z.

Biomed Pharmacother. 2023 May;161:114474. doi: 10.1016/j.biopha.2023.114474. Epub 2023 Mar 4.

Psychometric properties of the Alzheimer's Disease Cooperative Study - Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial

Potashman M, Pang M, Tahir M, Shahraz S, Dichter S, Perneczky R, Nolte S.

BMC Geriatr. 2023 Mar 6;23(1):124. doi: 10.1186/s12877-022-03527-0.

Kaempferol as a therapeutic agent in Alzheimer's disease: Evidence from preclinical studies

Dong X, Zhou S, Nao J.

Ageing Res Rev. 2023 Jun;87:101910. doi: 10.1016/j.arr.2023.101910. Epub 2023 Mar 15.

Re-remembering the influence of randomized β-carotene on cognitive decline

Kopec RE, Chasman DI, Okereke OI, Sesso HD.

Alzheimers Dement. 2023 Aug;19(8):3718-3721. doi: 10.1002/alz.13018. Epub 2023 Mar 20.

New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease

Pradhan SP, Sahu PK, Behera A.

Mol Cell Biochem. 2023 Dec;478(12):2739-2762. doi: 10.1007/s11010-023-04696-1. Epub 2023 Mar 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias